Coeptis Therapeutics

Quarterly Financials

Values in thousands 2024-06-30 2024-03-31 2023-12-31 2023-09-30
Revenue
$1,501
$0
$1,501
$0
Gross Profit
-250
-250
1,251
-250
EBITDA
-2,577
-2,672
-3,115
-7,599
EBIT
-2,828
-2,715
-3,159
-7,560
Net Income
-3,035
-3,001
-3,755
-6,260
Net Change In Cash
1,501
0
1,501
0
Free Cash Flow
-1,417
-1,902
-1,693
-1,958
Cash
1,555
1,029
1,469
1,411
Basic Shares
37,569
35,544
35,331
26,650

Annual Financials

Values in thousands 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Revenue
$0
$0
$75
$30
Gross Profit
-1,001
-1,001
-372
-933
EBITDA
-32,960
-32,960
-12,812
-8,684
EBIT
-33,962
-33,189
-13,260
-9,008
Net Income
-40,967
-40,967
-14,422
-7,009
Net Change In Cash
0
0
75
30
Free Cash Flow
-3,875
-3,875
-6,239
-3,136
Cash
3,791
3,791
2,179
202
Basic Shares
14,295
14,295
20,441
20,441

Earnings Calls

Quarter EPS
2024-06-30
-$0.08
2024-03-31
-$0.08
2023-12-31
-$0.11
2023-09-30
-$0.23